AI ultrasound probe market seen reaching $0.91 billion by 2030

The Business Research Company says the real-time follicle counting AI ultrasound probe market is set to grow from $0.49 billion in 2025 to $0.91 billion by 2030. The forecast points to rising infertility rates, wider use of assisted reproduction, and faster adoption of AI-powered fertility diagnostics.

Why it matters: - Real-time follicle counting AI ultrasound probes are becoming a more important tool in fertility care. - The technology is aimed at improving follicle monitoring, reducing diagnostic inconsistency, and supporting assisted reproductive treatment decisions. - The market’s projected growth reflects rising demand for more precise fertility diagnostics as infertility rates increase worldwide.

What happened: - The Business Research Company forecast the real-time follicle counting AI ultrasound probe market will grow to $0.91 billion by 2030. - The market is projected to rise from $0.49 billion in 2025 to $0.55 billion in 2026. - The forecast was published Oct. 22, 2026. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the next several years. - The company made a free sample report available here. - The company also made the full report available here.

The details: - The market is expected to post a 13.1% CAGR in the historical period from 2025 to 2026. - The forecast through 2030 implies a 13.3% CAGR. - The report links growth to rising demand for fertility diagnostics, broader use of assisted reproductive technologies, increasing infertility, fertility clinic expansion, and the need for more accurate follicle monitoring. - The report says AI-powered ultrasound analysis, real-time fertility monitoring, reduced diagnostic inconsistency, digital transformation in reproductive healthcare, and higher investment in advanced medical imaging will support future growth. - The technology combines AI with ultrasound imaging to count and assess ovarian follicles in real time. - The technology is designed to reduce manual intervention and variation in follicle evaluation. - The report says the result is better clinical decision-making, shorter examination times, improved patient outcomes, and further digitization of reproductive healthcare. - The report cites the World Health Organization as saying that about 17.5% of adults globally, or roughly one in six people, experienced infertility in April 2023. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The 2026 report package includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and key technology and future trend analysis.

Between the lines: - The market story is being driven less by hardware alone and more by software-enabled workflow gains in fertility clinics. - AI is being positioned as a way to standardize a labor-intensive diagnostic step that directly affects assisted reproduction outcomes. - The regional split suggests mature adoption in North America and faster expansion potential in Asia-Pacific, where fertility services may still be scaling.

What's next: - Growth will likely track continued adoption of AI-based fertility imaging and automated follicle assessment tools. - More investment in digital reproductive health workflows could accelerate use in fertility clinics and assisted reproduction centers. - The market may continue to favor products that improve precision while cutting exam time and clinician workload.

The bottom line: - Real-time follicle counting AI ultrasound probes are moving from a niche fertility tool to a faster-growing global diagnostic category.